Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mwangelwa Mubiana‐Mbewe

Biographic Data

ID7731529
NAMEMwangelwa Mubiana‐Mbewe
GIVEN NAMESMwangelwa
FAMILY NAMEMubiana‐Mbewe
SIGNATUREMBEWE M M
AFFILIATIONSCentre for Infectious Disease Research in Zambia
ORCID0000-0002-7122-842X
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2016
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia

    Open Access•Dorothy C Nyemba, Emma Kalk et al.•ARTICLE•BMC Public Health•2022

    Infant growth trajectories differed by country, highlighting the importance of studying contextual influences on outcomes of infants who were HEU

  • Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia

    Open Access•Mwangelwa Mubiana‐Mbewe, Samuel Bosomprah et al.•ARTICLE•AIDS and Behavior•2020

  • Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe

    Open Access•for the PROMISE study team, Lynda Stranix‐Chibanda et al.•ARTICLE•AIDS and Behavior•2019

    The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …

  • A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period

    Angela M Bengtson, Carla J Chibwesha et al.•ARTICLE•AIDS Care•2016

    Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnant and breastfeeding women throughout sub-Saharan Africa (SSA). For this strategy to meaningfully improve maternal HIV outcomes, retention in HIV care is essential. We developed a risk score to identify women with high likelihood of loss to follow-up (LTFU) at 6 months postpartum from HIV care, using data from public health facilities in Lusaka, Zam…

  • Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia

    Open Access•Nancy L Hancock, Carla J Chibwesha et al.•ARTICLE•BMC Public Health•2016

    While FP-ART integration may be a promising strategy for increasing FP service uptake, such services must focus on assessing sexual activity and advocating for dual method use to increase effective contraceptive use and prevent unintended pregnancies

No prominent works on this page.

  • A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period

    Angela M Bengtson, Carla J Chibwesha et al.•ARTICLE•AIDS Care•2016

    Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnant and breastfeeding women throughout sub-Saharan Africa (SSA). For this strategy to meaningfully improve maternal HIV outcomes, retention in HIV care is essential. We developed a risk score to identify women with high likelihood of loss to follow-up (LTFU) at 6 months postpartum from HIV care, using data from public health facilities in Lusaka, Zam…

  • Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia

    Open Access•Nancy L Hancock, Carla J Chibwesha et al.•ARTICLE•BMC Public Health•2016

    While FP-ART integration may be a promising strategy for increasing FP service uptake, such services must focus on assessing sexual activity and advocating for dual method use to increase effective contraceptive use and prevent unintended pregnancies

  • Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe

    Open Access•for the PROMISE study team, Lynda Stranix‐Chibanda et al.•ARTICLE•AIDS and Behavior•2019

    The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …

  • Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia

    Open Access•Mwangelwa Mubiana‐Mbewe, Samuel Bosomprah et al.•ARTICLE•AIDS and Behavior•2020

  • Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia

    Open Access•Dorothy C Nyemba, Emma Kalk et al.•ARTICLE•BMC Public Health•2022

    Infant growth trajectories differed by country, highlighting the importance of studying contextual influences on outcomes of infants who were HEU

HIV/AIDS Research and Interventions (5 works) · Medicine (5 works) · Adolescent Sexual and Reproductive Health (4 works) · Internal Medicine (4 works) · Demography (3 works) · Environmental health (3 works) · HIV, Drug Use, Sexual Risk (3 works) · Nursing (3 works) · Obstetrics (3 works) · Population (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae